{"id":"W4408942933","doi":"10.6004/jnccn.2024.7252","title":"TIP25-243: Randomized Study Evaluating Optimal Dose, Efficacy and Safety of E7386 + Lenvatinib Versus Treatment of Physicians' Choice in Advance/Recurrent Endometrial Carcinoma Previously Treated With Anti-PD-(L)1 Immunotherapy","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Lenvatinib; Medicine; Immunotherapy; Oncology; Endometrial cancer; Internal medicine; Randomized controlled trial; Carcinoma; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006213981,0.0002638973,0.001396157,0.0002777766,0.00009721424,0.00001270704,0.0001656545,0.00005856827,0.00002378964],"category_scores_gemma":[0.0002306494,0.0001610706,0.0003437792,0.001108032,0.0002421149,0.00008426765,0.00002961273,0.0002135453,5.582231e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006106244,"about_ca_system_score_gemma":0.0006260665,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001585893,"about_ca_topic_score_gemma":0.00004337585,"domain_scores_codex":[0.9971298,0.0005570313,0.001155478,0.0002189496,0.0007231566,0.0002155824],"domain_scores_gemma":[0.9944662,0.002712475,0.001357176,0.0001691522,0.001263237,0.00003179951],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8684163,0.00136609,0.05308789,0.00008474557,0.004496042,0.00000473065,0.001061215,0.02532452,0.005835702,0.00001925387,0.0001404871,0.04016301],"study_design_scores_gemma":[0.5571454,0.00701343,0.4300621,0.001604793,0.0008779678,0.00001081424,0.0002626503,0.001001898,0.001014048,0.00001389506,0.0008465925,0.0001464877],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9632636,0.03314748,0.00003458995,0.0003387201,0.0007090183,0.002389251,0.00002077551,0.000004481476,0.00009202526],"genre_scores_gemma":[0.9955534,0.003264804,0.0005284032,0.0001201723,0.0004074633,0.00005816782,0.00000601947,0.00001768142,0.00004385008],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3769742,"threshold_uncertainty_score":0.6568267,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.049249119791007,"score_gpt":0.3769303939944209,"score_spread":0.3276812742034139,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}